346 related articles for article (PubMed ID: 23043191)
1. A 2011 survey of clinical practice patterns in the management of Graves' disease.
Burch HB; Burman KD; Cooper DS
J Clin Endocrinol Metab; 2012 Dec; 97(12):4549-58. PubMed ID: 23043191
[TBL] [Abstract][Full Text] [Related]
2. A 2013 survey of clinical practice patterns in the management of primary hypothyroidism.
Burch HB; Burman KD; Cooper DS; Hennessey JV
J Clin Endocrinol Metab; 2014 Jun; 99(6):2077-85. PubMed ID: 24527720
[TBL] [Abstract][Full Text] [Related]
3. 2021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease.
Parameswaran R; de Jong MC; Kit JLW; Sek K; Nam TQ; Thang TV; Khue NT; Aye TT; Tun PM; Cole T; Miller JA; Villa M; Khiewvan B; Sirinvaravong S; Sin YL; Muhammad R; Jap TS; Agrawal A; Rajput R; Fernando R; Sumanatilleke M; Suastika K; Shong YK; Lang B; Bartalena L; Yang SP;
Endocrine; 2023 Jan; 79(1):135-142. PubMed ID: 36129592
[TBL] [Abstract][Full Text] [Related]
4. A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules.
Burch HB; Burman KD; Cooper DS; Hennessey JV; Vietor NO
J Clin Endocrinol Metab; 2016 Jul; 101(7):2853-62. PubMed ID: 27014951
[TBL] [Abstract][Full Text] [Related]
5. A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA.
Beshyah SA; Khalil AB; Sherif IH; Benbarka MM; Raza SA; Hussein W; Alzahrani AS; Chadli A
Endocr Pract; 2017 Mar; 23(3):299-308. PubMed ID: 27967219
[TBL] [Abstract][Full Text] [Related]
6. A 2017 SURVEY OF THE CLINICAL PRACTICE PATTERNS IN THE MANAGEMENT OF RELAPSING GRAVES DISEASE.
Koren S; Shteinshnaider M; Or K; Cantrell D; Benbassat CA; Koren R
Endocr Pract; 2019 Jan; 25(1):55-61. PubMed ID: 30383500
[TBL] [Abstract][Full Text] [Related]
7. A 2013 European survey of clinical practice patterns in the management of Graves' disease.
Bartalena L; Burch HB; Burman KD; Kahaly GJ
Clin Endocrinol (Oxf); 2016 Jan; 84(1):115-20. PubMed ID: 25581877
[TBL] [Abstract][Full Text] [Related]
8. A 2023 International Survey of Clinical Practice Patterns in the Management of Graves' Disease: A Decade of Change.
Villagelin D; Cooper DS; Burch HB
J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38577717
[TBL] [Abstract][Full Text] [Related]
9. Management of Graves' disease: an overview and comparison of clinical practice guidelines with actual practice trends.
Muldoon BT; Mai VQ; Burch HB
Endocrinol Metab Clin North Am; 2014 Jun; 43(2):495-516. PubMed ID: 24891174
[TBL] [Abstract][Full Text] [Related]
10. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey.
Hookham J; Collins EE; Allahabadia A; Balasubramanian SP
Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964
[TBL] [Abstract][Full Text] [Related]
11. Differences and similarities in the treatment of diffuse goiter in Europe and the United States.
Wartofsky L; Glinoer D; Solomon B; Lagasse R
Exp Clin Endocrinol; 1991 May; 97(2-3):243-51. PubMed ID: 1717298
[TBL] [Abstract][Full Text] [Related]
12. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.
Wartofsky L; Glinoer D; Solomon B; Nagataki S; Lagasse R; Nagayama Y; Izumi M
Thyroid; 1991; 1(2):129-35. PubMed ID: 1688014
[TBL] [Abstract][Full Text] [Related]
13. International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China.
Tominaga T; Yokoyama N; Nagataki S; Cho BY; Koh CS; Chen JL; Shi Y
Thyroid; 1997 Apr; 7(2):217-20. PubMed ID: 9133688
[TBL] [Abstract][Full Text] [Related]
14. The management of Graves' disease in New Zealand: results of a national survey.
Ford HC; Delahunt JW; Feek CM
N Z Med J; 1991 Jun; 104(914):251-2. PubMed ID: 2057150
[TBL] [Abstract][Full Text] [Related]
15. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
Krassas GE; Segni M; Wiersinga WM
Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
[TBL] [Abstract][Full Text] [Related]
16. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
Bahn RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
Endocr Pract; 2011; 17(3):456-520. PubMed ID: 21700562
[TBL] [Abstract][Full Text] [Related]
17. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
[TBL] [Abstract][Full Text] [Related]
19. Current Diagnosis and Management of Graves' Disease.
Subekti I; Pramono LA
Acta Med Indones; 2018 Apr; 50(2):177-182. PubMed ID: 29950539
[TBL] [Abstract][Full Text] [Related]
20. Management of Hyperthyroidism in Pregnancy: Results of a Survey among Members of the European Thyroid Association.
Poppe K; Hubalewska-Dydejczyk A; Laurberg P; Negro R; Vermiglio F; Vaidya B
Eur Thyroid J; 2012 Apr; 1(1):34-40. PubMed ID: 25422798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
